Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
City & Markets

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030

By MarketWatch

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030

The weight-loss-drug manufacturer failed to excite investors hoping for a turnaround.

Read at source

Read also
  1. Novo shares slide as drugmaker lays out post-Wegovy growth strategy
  2. Global stock markets bounce higher; government bond yields tumble as oil slides – business live
  3. ‘She says it’s just money’: My friend pays for everything. I should be grateful, but I can’t stand her anymore.
  4. Nissan eyes increasing U.S. production as new Rogue hybrid launches
  5. All the signs say another financial crisis is coming. Here’s why we need to prepare for it now | Larry Elliott

Source: MarketWatch